Deadline: Claim your Certificate of Attendance and CME/CE credits by Friday, November 13, 2026. The Evaluation Site closes after this date.
It is ethically appropriate for providers to treat women who are at elevated risk provided that the women are carefully assessed, that specialists in their medical condition are consulted as
The American Society for Reproductive Medicine encourages all stakeholders with an interest in gamete and embryo donation to adopt directed (identified) in lieu of ‘‘known’’ and nonidentified in
Because the practice of preimplantation sex selection is ethically controversial, clinics are encouraged to develop and make available their policies regarding its use. Practitioners offering
A number of key misidentification risk points occur during an in vitro fertilization cycle in the laboratory that require robust witnessing.
The purpose of this ASRM Practice Committee Opinion is to provide clinicians with strategies and special considerations for the evaluation and treatment of individuals in the LGBTQ+ community.
At a minimum, all medical guidelines applicable to women donating fresh (non-cryopreserved) oocytes should also apply to women donating oocytes to an oocyte (egg) bank. These include informed
Explore ASRM Special Interest Groups connecting reproductive medicine professionals with shared clinical and research interests.
Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment.
Patients preparing to undergo gonadotoxic medical therapy, radiation therapy, or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation for
This review evaluates if uterine myomas impact likelihood of pregnancy and pregnancy loss, and if myomectomy influences pregnancy outcomes.
Displaying 1601 to 1610 of 1755 records
